Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways

Overview of attention for article published in Experimental Hematology & Oncology, April 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways https://t.co/6jNEtZuAus #AML #leusm #hematology https://t.co/Eaj0uMOoYQ

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.